drug eluting stent implantation in the left main coronary artery after coronary artery bypass graft相关文献:
Management of Restenosis after Stenting in Left Main Coronary Artery Disease.
Huang CW, Huang MS, Su PF, Chao TH, Lee CH, Liu PY.
Acta Cardiol Sin. 2023 Mar;39(2):277-286. doi: 10.6515/ACS.202303_39(2).20220821A.
PMID:36911551
Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease.
Chen X, Zhang X, Yan Y, Zhao X, Nie M, Feng T, Liang Z, Zhao Q.
Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany.
Stachon P, Kaier K, Hehn P, Peikert A, Wolf D, Oettinger V, Staudacher D, Duerschmied D, Zirlik A, Zehender M, Bode C, von Zur Mühlen C.
Clin Res Cardiol. 2022 Jul;111(7):742-749. doi: 10.1007/s00392-021-01931-x. Epub 2021 Aug 28.
PMID:34453576
Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis.
Wang Z, Gong Y, Fan F, Yang F, Qiu L, Hong T, Huo Y.
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.
Prognostic Impact of Target Lesion Revascularization on Long-Term Cardiac Mortality After Current-Generation Drug-Eluting Stent Implantation for Left Main Distal Bifurcation: the Milan and New-Tokyo (MITO) Registry.
Watanabe Y, Mitomo S, Naganuma T, Chieffo A, Montorfano M, Nakamura S, Colombo A.
Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials.
Sotomi Y, Onuma Y, Cavalcante R, Ahn JM, Lee CW, van Klaveren D, de Winter RJ, Wykrzykowska JJ, Farooq V, Morice MC, Steyerberg EW, Park SJ, Serruys PW.
Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW, Ahn JM, Cavalcante R, Sotomi Y, Onuma Y, Suwannasom P, Tenekecioglu E, Yun SC, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Serruys PW, Park SJ.
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2481-2489. doi: 10.1016/j.jcin.2016.10.008.
PMID:28007199
Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.
Chang M, Lee CW, Ahn JM, Cavalcante R, Sotomi Y, Onuma Y, Han M, Park SW, Serruys PW, Park SJ.
Catheter Cardiovasc Interv. 2017 Aug 1;90(2):177-185. doi: 10.1002/ccd.26927. Epub 2017 Jan 23.
PMID:28112467
Impact of Multivessel Coronary Artery Disease With Versus Without Left Main Coronary Artery Disease on Long-Term Mortality After Coronary Bypass Grafting Versus Drug-Eluting Stent Implantation.
Chang M, Lee CW, Ahn JM, Cavalcante R, Sotomi Y, Onuma Y, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Serruys PW, Park SJ.
Am J Cardiol. 2017 Jan 15;119(2):225-230. doi: 10.1016/j.amjcard.2016.09.048. Epub 2016 Oct 8.